Date | Chamber | Action |
1/11/2005 | House | Session Sine Die |
305 ILCS 5/5-5.12 | from Ch. 23, par. 5-5.12 |
Fiscal Note (Department of Public Aid) | |
This bill will hamper the Department's ability to enact cost containment measures if prior approval, generic preference and formulary restrictions are exempt for clients diagnosed with a specific disease such as reversible obstructive airway disease. It is also difficult to link comprehensive drugs to a particular disease, since drug prescriptions do not include a diagnosis field. Computer system changes related to such diagnosis tracking will result in increased administrative costs and would need to conform to HIPAA requirements. Since the Department does not track Medicaid clients by their disease, fiscal impact cannot be determined at this time. |
Date | Chamber | Action | 2/5/2004 | House | Filed with the Clerk by Rep. Arthur L. Turner | 2/5/2004 | House | First Reading | 2/5/2004 | House | Referred to Rules Committee | 2/19/2004 | House | Assigned to Human Services Committee | 2/25/2004 | House | Added Chief Co-Sponsor Rep. Carolyn H. Krause | 2/25/2004 | House | Added Chief Co-Sponsor Rep. Elizabeth Coulson | 2/26/2004 | House | Added Co-Sponsor Rep. Sara Feigenholtz | 2/26/2004 | House | Added Co-Sponsor Rep. Mary E. Flowers | 2/26/2004 | House | Added Chief Co-Sponsor Rep. Dave Winters | 2/26/2004 | House | Added Chief Co-Sponsor Rep. Kenneth Dunkin | 2/26/2004 | House | Added Co-Sponsor Rep. Paul D. Froehlich | 3/4/2004 | House | Do Pass / Short Debate Human Services Committee; 008-000-000 | 3/4/2004 | House | Placed on Calendar 2nd Reading - Short Debate | 3/22/2004 | House | Fiscal Note Filed | 3/31/2004 | House | Second Reading - Short Debate | 3/31/2004 | House | Held on Calendar Order of Second Reading - Short Debate | 4/2/2004 | House | Rule 19(a) / Re-referred to Rules Committee | 1/11/2005 | House | Session Sine Die |